Beijing Airdoc Technology Co., Ltd., a leading artificial intelligence (AI)-powered ophthalmology device company, has announced plans to invest RMB 250 million in the establishment of a joint venture (JV) with two Chinese investment firms. The JV, which will have a total capitalization of RMB 500 million, will focus on strategic investments in the sectors of life sciences, healthcare services, smart healthcare, and artificial intelligence.
This collaboration aims to leverage the expertise of each partner to identify and support innovative projects within the rapidly growing healthcare and AI industries. The joint venture will target opportunities that align with the long-term vision of advancing healthcare technology and improving patient outcomes through the application of AI and smart healthcare solutions. – Flcube.com
